Strata Skin's Shares Plummet as Laseroptek Files Counterclaims for Unfair Business Practices

Thursday, Feb 12, 2026 9:41 am ET1min read
SSKN--

Strata Skin Sciences shares have plummeted 60% in pre-market trading after Laseroptek America filed counterclaims and third-party claims against the company and its CEO. Laseroptek alleges unfair competition, anticompetitive practices, and defamation. The counterclaims dispute reimbursement codes, product performance comparisons, and patent misrepresentations. Strata Skin markets XTRAC lasers, VTRAC lamp systems, and TheraClearX Acne Therapy System. The stock is currently trading at $0.46, down 61.61%.

Strata Skin's Shares Plummet as Laseroptek Files Counterclaims for Unfair Business Practices

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet